These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12100732)

  • 1. Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.
    Cull VS; Bartlett EJ; James CM
    Immunology; 2002 Jul; 106(3):428-37. PubMed ID: 12100732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.
    Bartlett EJ; Cull VS; Brekalo NL; Lenzo JC; James CM
    Immunol Cell Biol; 2002 Oct; 80(5):425-35. PubMed ID: 12225378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor.
    Lenzo JC; Fairweather D; Shellam GR; Lawson CM
    Cell Immunol; 2001 Oct; 213(1):52-61. PubMed ID: 11747356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-alpha therapy.
    Lenzo JC; Mansfield JP; Sivamoorthy S; Cull VS; James CM
    Cell Immunol; 2003 May; 223(1):77-86. PubMed ID: 12914761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice.
    Cull VS; Broomfield S; Bartlett EJ; Brekalo NL; James CM
    Gene Ther; 2002 Oct; 9(20):1369-78. PubMed ID: 12365002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin.
    Fairweather D; Lawson CM; Chapman AJ; Brown CM; Booth TW; Papadimitriou JM; Shellam GR
    Immunology; 1998 Jun; 94(2):263-70. PubMed ID: 9741351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.
    Presti RM; Pollock JL; Dal Canto AJ; O'Guin AK; Virgin HW
    J Exp Med; 1998 Aug; 188(3):577-88. PubMed ID: 9687534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis.
    Ritter JT; Tang-Feldman YJ; Lochhead GR; Estrada M; Lochhead S; Yu C; Ashton-Sager A; Tuteja D; Leutenegger C; Pomeroy C
    Cardiovasc Pathol; 2010; 19(2):83-93. PubMed ID: 19217318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
    Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
    Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
    MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
    J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus.
    Noda S; Tanaka K; Sawamura S; Sasaki M; Matsumoto T; Mikami K; Aiba Y; Hasegawa H; Kawabe N; Koga Y
    J Immunol; 2001 Mar; 166(5):3533-41. PubMed ID: 11207313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
    Roback JD; Hossain MS; Lezhava L; Gorechlad JW; Alexander SA; Jaye DL; Mittelstaedt S; Talib S; Hearst JE; Hillyer CD; Waller EK
    J Immunol; 2003 Dec; 171(11):6023-31. PubMed ID: 14634114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular viral replication after systemic murine cytomegalovirus infection requires immunosuppression.
    Gao EK; Yu XH; Lin CP; Zhang H; Kaplan HJ
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2322-7. PubMed ID: 7558728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT2-Dependent Immune Responses Ensure Host Survival despite the Presence of a Potent Viral Antagonist.
    Le-Trilling VTK; Wohlgemuth K; Rückborn MU; Jagnjic A; Maaßen F; Timmer L; Katschinski B; Trilling M
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vgamma1+ gammadelta T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-gamma.
    Ninomiya T; Takimoto H; Matsuzaki G; Hamano S; Yoshida H; Yoshikai Y; Kimura G; Nomoto K
    Immunology; 2000 Feb; 99(2):187-94. PubMed ID: 10692035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
    Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
    PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon.
    Heise MT; Pollock JL; O'Guin A; Barkon ML; Bormley S; Virgin HW
    Virology; 1998 Feb; 241(2):331-44. PubMed ID: 9499808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous Immunity and Persistent Murine Cytomegalovirus Infection.
    Che JW; Daniels KA; Selin LK; Welsh RM
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.